Published in
Wiley Open Access, Cancer Science, 9(113), p. 3169-3179, 2022
DOI: 10.1111/cas.15474
Links
Tools
Pertuzumab retreatment for HER2 ‐positive advanced breast cancer: a randomized, open‐label phase III study ( PRECIOUS )
Journal article published in 2022 by
Yutaka Yamamoto 
,
Hiroji Iwata,
Naruto Taira ,
Norikazu Masuda ,
Masato Takahashi ,
Tetsuhiro Yoshinami,
Takayuki Ueno ,
Tatsuya Toyama ,
Takashi Yamanaka,
Toshimi Takano,
Masahiro Kashiwaba,
Koichiro Tsugawa,
Yoshie Hasegawa,
Kenji Tamura ,
Hiroshi Tada
and other authors.
,
Hiroji Iwata,
Naruto Taira ,
Norikazu Masuda ,
Masato Takahashi ,
Tetsuhiro Yoshinami,
Takayuki Ueno ,
Tatsuya Toyama ,
Takashi Yamanaka,
Toshimi Takano,
Masahiro Kashiwaba,
Koichiro Tsugawa,
Yoshie Hasegawa,
Kenji Tamura ,
Hiroshi Tada
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Data provided by 